Year: 2019
Resolution Number: 54
Action Taken: Approved
Status:
Author(s): Tabitha Moses
Sponsor: Charles J. Barone II, MD
On behalf of: Wayne County Delegation
Committee: D (Public Health)
Resolved Section(s):
RESOLVED: That MSMS supports the implementation of naloxone box stations in high risk areas throughout the state; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to support the legal access to and use of naloxone in all public spaces regardless of whether the individual holds a prescription; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to amend policy H-95.932, “Increasing Availability of Naloxone,” by insertion and deletion as follows: 1. Our AMA supports legislative, regulatory, and national advocacy efforts to increase access to affordable naloxone, including but not limited to collaborative practice agreements with pharmacists and standing orders for pharmacies and, where permitted by law, community-based organizations, law enforcement agencies, correctional settings, schools, and other locations that do not restrict the route of administration for naloxone delivery. 2. Our AMA supports efforts that enable law enforcement agencies to carry and administer naloxone. 3. Our AMA encourages physicians to co-prescribe naloxone to patients at risk of overdose and, where permitted by law, to the friends and family members of such patients. 4. Our AMA encourages private and public payers to include all forms of naloxone on their preferred drug lists and formularies with minimal or no cost sharing. 5. Our AMA supports liability protections for physicians and other health care professionals and others who are authorized to prescribe, dispense and/or administer naloxone pursuant to state law. 6. Our AMA supports efforts to encourage individuals who are authorized to administer naloxone to receive appropriate education to enable them to do so effectively. 7. Our AMA encourages manufacturers or other qualified sponsors to pursue the application process for over the counter approval of naloxone with the Food and Drug Administration. 8. Our AMA urges the Food and Drug Administration to study the practicality and utility of supports the widespread implementation of easily accessible Naloxone rescue stations (public availability of Naloxone through wall-mounted display/storage units that also include instructions) throughout the country following distribution and legislative edicts similar to those for Automated External Defibrillators.
RESOLVED: That MSMS supports the implementation of naloxone box stations in high risk areas throughout the state; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to support the legal access to and use of naloxone in all public spaces regardless of whether the individual holds a prescription; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to amend policy H-95.932, “Increasing Availability of Naloxone,” by insertion and deletion as follows: 1. Our AMA supports legislative, regulatory, and national advocacy efforts to increase access to affordable naloxone, including but not limited to collaborative practice agreements with pharmacists and standing orders for pharmacies and, where permitted by law, community-based organizations, law enforcement agencies, correctional settings, schools, and other locations that do not restrict the route of administration for naloxone delivery. 2. Our AMA supports efforts that enable law enforcement agencies to carry and administer naloxone. 3. Our AMA encourages physicians to co-prescribe naloxone to patients at risk of overdose and, where permitted by law, to the friends and family members of such patients. 4. Our AMA encourages private and public payers to include all forms of naloxone on their preferred drug lists and formularies with minimal or no cost sharing. 5. Our AMA supports liability protections for physicians and other health care professionals and others who are authorized to prescribe, dispense and/or administer naloxone pursuant to state law. 6. Our AMA supports efforts to encourage individuals who are authorized to administer naloxone to receive appropriate education to enable them to do so effectively. 7. Our AMA encourages manufacturers or other qualified sponsors to pursue the application process for over the counter approval of naloxone with the Food and Drug Administration. 8. Our AMA urges the Food and Drug Administration to study the practicality and utility of supports the widespread implementation of easily accessible Naloxone rescue stations (public availability of Naloxone through wall-mounted display/storage units that also include instructions) throughout the country following distribution and legislative edicts similar to those for Automated External Defibrillators.
Fiscal Note: $1,000 or more for costs related to the adoption of new or revised MSMS or AMA policy.
Resolution: View PDF for Availability of Naloxone Boxes
For More Information, Contact: